MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, NWBO has $80,051K in assets. $118,111K in debts. $1,786K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
7.47%
Quick Ratio
7.47%
Cash Ratio
2.15%
Debt to Asset Ratio
147.54%
Unit: Thousand (K) dollars
Assets Breakdown
    • Prepaid expenses and other curre...
    • Right-of-use asset, net
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable and accrued exp...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
1,786 3,040 4,560 4,316
Prepaid expenses and other current assets
4,416 2,166 2,327 1,839
Loan receivable
-311 311 -
Total current assets
6,202 5,517 7,198 6,155
Property, plant and equipment, net
16,771 17,406 16,870 16,685
Right-of-use asset, net
4,050 4,197 4,265 4,419
Indefinite-lived intangible asset
--1,292 1,292
Intangible assets, net
52,048 53,188 --
Goodwill
626 626 626 626
Other assets
354 356 358 370
Total non-current assets
73,849 75,773 23,411 23,392
Total assets
80,051 81,290 30,609 29,547
Contingent payable derivative liability
-9,416 9,665 9,112
Accounts payable and accrued expenses
31,584 30,816 26,875 23,659
Accounts payable and accrued expenses to related parties and affiliates
--9,841 8,016
Convertible notes, net
740 640 818 793
Convertible notes at fair value
30,828 32,056 26,008 24,692
Notes payable, net
11,650 9,468 13,570 16,313
Warrant liability
---681
Investor advances
207 207 207 207
Share payable
370 373 522 -
Lease liabilities
274 374 399 448
Due to related party
7,320 8,350 --
Total current liabilities
82,973 91,700 87,905 83,921
Convertible notes, net of current portion
1,494 325 --
Convertible notes at fair value, net of current portion
7,513 5,220 24,617 13,772
Notes payable, net of current portion, net
7,204 12,333 7,188 9,166
Lease liabilities, net of current portion
4,291 4,411 4,447 4,624
Contingent payment obligation
1,700 1,700 1,700 4,700
Deferred tax liability
12,936 13,171 --
Total non-current liabilities
35,138 37,160 37,952 32,262
Total liabilities
118,111 128,860 125,857 116,183
Series c convertible preferred stock, 10,000,000 shares designated 766,747 shares and 784,347 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively aggregate liquidation preference of 11.0 million
12,484 12,710 13,400 13,753
Common stock (0.001 par value) 2,600,000,000 shares authorized 1,618.9 million and 1,567.4 million shares issued as of march 31, 2026 and december 31, 2025 1,606.9 million and 1,555.4 million shares outstanding as of march 31, 2026 and december 31, 2025, respectively
1,619 1,567 1,518 1,459
Treasury stock, 12,000,000 shares at march 31, 2026 and december 31, 2025, respectively
12 12 --
Additional paid-in capital
1,455,087 1,442,830 1,396,179 1,378,300
Stock subscription receivable
79 79 79 79
Accumulated deficit
-1,506,730 -1,503,661 -1,505,049 -1,478,220
Accumulated other comprehensive loss
-429 -925 -1,217 -1,849
Total stockholders' deficit
-50,544 -60,280 -108,648 -100,389
Total liabilities, mezzanine equity and stockholders' deficit
80,051 81,290 30,609 29,547
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Intangible assets, net$52,048K Property, plant andequipment, net$16,771K Right-of-use asset, net$4,050K Goodwill$626K Other assets$354K Prepaid expenses andother current assets$4,416K Cash and cashequivalents$1,786K Total non-currentassets$73,849K Total current assets$6,202K Total assets$80,051K Accumulated deficit-$1,506,730K Accumulated othercomprehensive loss-$429K Stock subscriptionreceivable$79K Treasury stock,12,000,000 shares at march...$12K Total liabilities,mezzanine equity and...$80,051K Total stockholders'deficit-$50,544K Additional paid-in capital$1,455,087K Common stock (0.001 parvalue) 2,600,000,000...$1,619K Total liabilities$118,111K Series c convertiblepreferred stock,...$12,484K Total currentliabilities$82,973K Total non-currentliabilities$35,138K Accounts payable andaccrued expenses$31,584K Convertible notes at fairvalue$30,828K Notes payable, net$11,650K Due to related party$7,320K Convertible notes, net$740K Share payable$370K Lease liabilities$274K Investor advances$207K Deferred tax liability$12,936K Convertible notes at fairvalue, net of current...$7,513K Notes payable, net ofcurrent portion, net$7,204K Lease liabilities,net of current...$4,291K Contingent paymentobligation$1,700K Convertible notes, net ofcurrent portion$1,494K

NORTHWEST BIOTHERAPEUTICS INC (NWBO)

NORTHWEST BIOTHERAPEUTICS INC (NWBO)